GuruTrack
HUM

HUM

HUMANA INC

Data as of 2026 Q1 (03-31) · 13F snapshot

Summary
HUMANA INC (HUM) is held by 14 tracked hedge-fund managers, a combined reported value of ~$1.06B; the largest are Ken Griffin, Dan Loeb, Andreas Halvorsen. This quarter: 2 new, 2 added, 1 trimmed, 1 closed. 20 members of Congress have disclosed STOCK Act trades. Data as of 2026 Q1, from public SEC 13F filings, delayed up to ~45 days.
Attention · HighThis quarter · Heating up
Gurus holding14
Congress trades20
Price$381.15vs quarter-end+119.82%
Sectors1
This quarter's moves
New2
Added2
Trimmed / sold2
Top holderKen Griffin
Ken GriffinCALL—
Value $181.18M— of portfolio1,044,9002026 Q1
Dan LoebTrim
Value $180.47M1.6% of portfolio750,0002017 Q2
Andreas HalvorsenNew
Value $160.92M0.6% of portfolio464,1302024 Q1
Ken GriffinPUT—
Value $106.95M— of portfolio616,8002026 Q1
Dan LoebCALL—
Value $103.07M— of portfolio500,0002017 Q1
Seth KlarmanNew large stake
Value $87.78M2.6% of portfolio346,0002024 Q4
David EinhornHold
Value $69.13M1.3% of portfolio384,3002016 Q2
Izzy EnglanderCALL—
Value $43.45M— of portfolio250,6002026 Q1
Stanley DruckenmillerNew
Value $23.84M0.8% of portfolio137,5052026 Q1
Izzy EnglanderPUT—
Value $13.56M— of portfolio78,2002026 Q1
Steven CohenCALL—
Value $7.54M— of portfolio43,5002026 Q1
Steven CohenPUT—
Value $1.92M— of portfolio11,1002026 Q1

Insider Trading

Officers · directors · Form 4

  • Kurt J Hilzinger

    Director

    Buy$91.4K
    233Traded 2026-06-30Filed 2026-07-02

  • Japan Mehta

    Chief Information Officer

    Buy
    9,448 @ $0.00Traded 2026-05-01Filed 2026-05-05

  • David Dintenfass

    President, Enterprise Growth

    Buy
    11,273 @ $0.00Traded 2026-05-01Filed 2026-05-05

  • James A. Rechtin

    President & CEO

    Buy
    35,633 @ $0.00Traded 2026-05-01Filed 2026-05-05

  • Michelle A. O'Hara

    Chief Human Resources Officer

    Buy
    10,485 @ $0.00Traded 2026-05-01Filed 2026-05-05

  • Robert Stuart Field

    Director

    Buy
    852 @ $0.00Traded 2026-05-01Filed 2026-05-05

  • Joseph C Ventura

    Chief Legal Officer

    Buy
    10,318 @ $0.00Traded 2026-05-01Filed 2026-05-05

  • Sanjay K Shetty

    President, CenterWell

    Buy
    9,945 @ $0.00Traded 2026-05-01Filed 2026-05-05

  • Aaron Martin

    President, Medicare Advantage

    Buy
    8,206 @ $0.00Traded 2026-05-01Filed 2026-05-05

  • Celeste Mellet

    Chief Financial Officer

    Buy
    15,387 @ $0.00Traded 2026-05-01Filed 2026-05-05

  • Sanjay K Shetty

    President, CenterWell

    Sell$70.4K
    401 @ $175.44Traded 2026-04-01Filed 2026-04-03

  • Sanjay K Shetty

    President, CenterWell

    Buy
    887 @ $0.00Traded 2026-04-01Filed 2026-04-03

  • Kurt J Hilzinger

    Director

    Buy$91.5K
    536Traded 2026-03-31Filed 2026-04-02

  • George Renaudin II

    President, Insurance

    Sell$4.3K
    25Traded 2026-03-31Filed 2026-04-02

  • Joseph C Ventura

    Chief Legal Officer

    Sell$84.6K
    478 @ $177.07Traded 2026-02-24Filed 2026-02-26

  • George Renaudin II

    President, Insurance

    Buy
    1,035 @ $0.00Traded 2026-02-24Filed 2026-02-26

  • George Renaudin II

    President, Insurance

    Sell$74.2K
    419 @ $177.07Traded 2026-02-24Filed 2026-02-26

  • Joseph C Ventura

    Chief Legal Officer

    Buy
    1,035 @ $0.00Traded 2026-02-24Filed 2026-02-26

  • John-Paul W. Felter

    SVP, Chief Accting Off & Cont.

    Buy
    165 @ $0.00Traded 2026-02-23Filed 2026-02-25

  • John-Paul W. Felter

    SVP, Chief Accting Off & Cont.

    Sell$14.9K
    84 @ $177.07Traded 2026-02-23Filed 2026-02-25

  • Sanjay K Shetty

    President, CenterWell

    Buy$150.0K
    810 @ $185.21Traded 2026-02-23Filed 2026-02-25

  • John-Paul W. Felter

    SVP, Chief Accting Off & Cont.

    Buy
    5,669 @ $0.00Traded 2026-02-23Filed 2026-02-25

  • David Dintenfass

    President, Enterprise Growth

    Sell$224.2K
    1,182 @ $189.66Traded 2026-02-21Filed 2026-02-24

  • David Dintenfass

    President, Enterprise Growth

    Buy
    3,858 @ $0.00Traded 2026-02-21Filed 2026-02-24

Insider transactions are public SEC Form 4 disclosures (company officers, directors, 10% owners), for research only — not investment advice.

Data from public SEC 13F & STOCK Act filings, delayed up to ~45 days, partial holdings only — for research, not investment advice.